Form 4 for TBI TrueBlue, Inc.
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-04 · accession 0000768899-22-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-08 | 2022-02-04 | TBI | Kreidler Robert C. | Dir | A - Grant | $0.00 | +4,956 | 14.4K | +53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-04 | A | A | 4,956 | $0.00 | 14,395 | D | — | — | (F1) Represents a grant of restricted stock units that will be settled for shares of Common Stock on a one-for-one basis in the future. The restricted stock units will vest in full on September 26, 2022, which is the first day of the Issuer's fourth quarter in the current fiscal year. Delivery of the vested shares to the Reporting Person will be made ninety (90) days after his separation from service on the Board of Directors. (F2) This total includes 10,678 shares or restricted stock units, as applicable, deferred pursuant to the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors, of which 5,722 were previously reported in Table II. |